An RCOR1 loss–associated gene expression signature identifies a prognostically significant DLBCL subgroup-Reference-Cited by-同舟云学术

An RCOR1 loss–associated gene expression signature identifies a prognostically significant DLBCL subgroup

Published:2015-02-05 Issue:6 Volume:125 Page:959-966
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Chan Fong Chun¹²^ORCID,Telenius Adele¹,Healy Shannon¹,Ben-Neriah Susana¹,Mottok Anja¹,Lim Raymond¹^ORCID,Drake Marie¹,Hu Sandy¹,Ding Jiarui³^ORCID,Ha Gavin²³,Scott David W.¹,Kridel Robert¹,Bashashati Ali³,Rogic Sanja¹,Johnson Nathalie⁴,Morin Ryan D.⁵⁶^ORCID,Rimsza Lisa M.⁷,Sehn Laurie¹,Connors Joseph M.¹^ORCID,Marra Marco A.⁵⁸,Gascoyne Randy D.¹,Shah Sohrab P.³,Steidl Christian¹

Affiliation:

1. Center for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;

2. Bioinformatics Graduate Program, University of British Columbia, Vancouver, BC, Canada;

3. Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada;

4. Department of Oncology, McGill University, Montreal, QC, Canada;

5. Genome Sciences Center, British Columbia Cancer Agency, Vancouver, BC, Canada;

6. Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada;

7. Department of Pathology, University of Arizona, Tucson, AZ; and

8. Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada

Abstract

Key Points Integration of genome-wide copy number and whole transcriptome data identifies key mutational events in the pathogenesis of DLBCL. Genomic deletions in RCOR1 are associated with a specific gene expression signature and with unfavorable clinical outcomes in DLBCL patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/125/6/959/1387688/959.pdf

Reference37 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.;Alizadeh;Nature,2000

2. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.;Bea;Blood,2005

3. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.;Tagawa;Blood,2005

4. Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.;Jardin;Blood,2010

5. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.;Rosenwald;N Engl J Med,2002

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma;Proceedings of the National Academy of Sciences;2024-04-25

2. RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies;Clinical Pathology;2024-01

3. Comprehensive analysis of REST corepressors (RCORs) in pan-cancer;Frontiers in Cell and Developmental Biology;2023-06-05

4. Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma;Journal of Clinical Investigation;2022-05-16

5. Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma;Cancers;2022-03-05